skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: 125I implantation for carcinoma of prostate. Further follow-up of first 100 cases

Journal Article · · Urology (Ridgewood, N.J.); (United States)

Analysis of the first 100 patients at the Memorial Sloan-Kettering Cancer Center with Stage B or C prostatic cancer treated by pelvic lymph node dissection and Iodine-125 implantation and endocrine therapy when specifically indicated revealed five-year survival rates of 87 and 77 per cent, respectively. Tumor stage, tumor grade, and lymph node metastasis each correlated with survival, but the latter was the most significant factor. Although routine follow-up biopsies were not performed, local tumor control as judged by serial digital rectal examination defined a prognostically favored group of patients. In the absence of controls, however, whether the latter response indicates a salutary effect of the treatment which produces an improved survival or merely identifies a group of patients who were predetermined to have a more favorable survival is undetermined.

Research Organization:
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York
OSTI ID:
6221957
Journal Information:
Urology (Ridgewood, N.J.); (United States), Vol. 20:6
Country of Publication:
United States
Language:
English

Similar Records

Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression
Journal Article · Wed Feb 01 00:00:00 EST 2017 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6221957

The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 125I implantation
Journal Article · Thu Aug 01 00:00:00 EDT 1991 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6221957

Carcinoma of the prostate irradiated by combined I/sup 125/ and external irradiation, analysis of failure and significance of positive biopsy one year or more after therapy
Journal Article · Tue Mar 01 00:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6221957